Revised May 2013
Editorial Staff
- Editor, David Anderson, NIDA
- Managing Editor, Scott Edie, Ph.D., CSR
- Associate Editor, Kristin Blank, M.F.A., IQ Solutions
- Senior Science Writer, Susanne Hiller-Sturmhöfel, Ph.D., CSR
- Creative Director, Martín Castillo, IQ Solutions
- Content Coordinator, Stephen Pelkey, CSR
NIDA Notes Editorial Board Members
- David Anderson, Chair; Public Health Advisor, Office of Science Policy and Communications
- James Bjork, Ph.D., Program Official, Division of Clinical Neuroscience and Behavioral Research
- Kristopher Bough, Ph.D., Health Science Administrator, Division of Basic Neuroscience and Behavioral Research
- Cheryl Boyce, Ph.D., Branch Chief, Division of Clinical Neuroscience and Behavioral Research
- Redonna Chandler, Ph.D., Chief, Division of Epidemiology, Services, and Prevention Research
- Petra Jacobs, M.D., Associate Director for Program Development, Center for Clinical Trials Network
- Diane Lawrence, Ph.D., Health Scientist Administrator, Office of the Director, Aids Research Program
- Jacqueline Lloyd, Ph.D., Health Science Administrator, Division of Epidemiology, Services and Prevention Research
- Marsha F. Lopez, Ph.D., Health Science Administrator, Division of Epidemiology, Services and Prevention Research
- Minda Lynch, Ph.D., Chief, Behavioral and Cognitive Science Research Branch
- Ivan Montoya, M.D., M.P.H., Medical Officer, Division of Pharmacotherapies and Medical Consequences of Drug Abuse
- Lisa Onken, Ph.D., Project Officer, Behavioral and Integrative Treatment Branch
- Mary Pfeiffer, Ph.D., Editor and Writer, Intramural Research Program
- Nancy Pilotte, Ph.D., Chief, Functional Neuroscience Research Branch
- Kenzie Preston, Ph.D., Chief, Clinical Pharmacology and Therapeutics Research Branch
- John Satterlee, Ph.D., Program Director, Division of Basic Neuroscience and Behavioral Research
- Paul J. Wakim, Ph.D, Senior Mathematical Statistician, Center for Clinical Trials Network
- Eric Wargo, Ph.D., Science Writer, Office of Science Policy and Communications
- Cora Lee Wetherington, Ph.D., Psychologist, Division of Basic Neuroscience and Behavioral Research
Categories
Tags
Drug Topics
Drugs of Abuse
Population Groups
Related Topics
Attention
Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at
Looking for Treatment?
Use the SAMHSA Treatment Locator or 1-800-662-HELP.
Helpline open during government shutdown